Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (151-160 of 241) with videos related to

Pageof 25
Sort By:
Journal of Clinical Pathology|October 6, 2006
A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor alphaS Knop, M Schupp, E Wardelmann, et al.
British Journal of Haematology|May 1, 2001
High-grade lymphoma mimicking bone crisis in Gaucher's diseaseM Manz, R Riessen, L Poll, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumorsC Bokemeyer, J T Hartmann, F Mayer, et al.
Transplantation|August 15, 2001
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprintingH Schäfer, C Berger, C Aepinus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Cancer|July 19, 2002
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancerC Kollmannsberger, F Mayer, H Pressler, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantationW Brugger, P Brossart, S Scheding, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Blood|April 21, 2001
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cellsM Seiffert, P Brossart, C Cant, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Pageof 25

Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Journal of Clinical Pathology|October 6, 2006
A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor alphaS Knop, M Schupp, E Wardelmann, et al.
British Journal of Haematology|May 1, 2001
High-grade lymphoma mimicking bone crisis in Gaucher's diseaseM Manz, R Riessen, L Poll, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumorsC Bokemeyer, J T Hartmann, F Mayer, et al.
Transplantation|August 15, 2001
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprintingH Schäfer, C Berger, C Aepinus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Cancer|July 19, 2002
Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancerC Kollmannsberger, F Mayer, H Pressler, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantationW Brugger, P Brossart, S Scheding, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Blood|April 21, 2001
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cellsM Seiffert, P Brossart, C Cant, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Pageof 25